Deschambault, Canada

Martin Simard

This inventor holds 7 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: University of Massachusetts. Active years: 2010-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Simard. Retrieved from https://idiyas.com/inventor/martin-simard

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0



Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 412(Granted Patents)


Location History:

  • Deschambault, CA (US) (2012)
  • Deschambault, CA (2010 - 2020)

Company Filing History:


Years Active: 2010-2020

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Martin Simard: Innovator in RNA Silencing Technologies

Introduction

Martin Simard is a prominent inventor based in Deschambault, Canada. He has made significant contributions to the field of RNA silencing, holding a total of seven patents. His work focuses on enhancing the efficacy and specificity of RNA silencing, which has important implications for therapeutic methods.

Latest Patents

Among his latest patents, Martin Simard has developed methods and compositions for enhancing the efficacy and specificity of RNA silencing. This invention provides innovative methods for mediating RNA silencing, including the use of siRNAs, siRNA-like molecules, shRNAs, vectors, and transgenes. These advancements aim to improve the specificity and efficacy in silencing target genes, which is crucial for therapeutic applications.

Career Highlights

Martin Simard is affiliated with the University of Massachusetts, where he continues to advance research in RNA technologies. His work has garnered attention for its potential to revolutionize therapeutic approaches in genetic research and medicine.

Collaborations

Some of his notable coworkers include Phillip D. Zamore and Dianne S. Schwarz, who have collaborated with him on various projects related to RNA silencing.

Conclusion

Martin Simard's innovative work in RNA silencing technologies positions him as a key figure in the field. His contributions are paving the way for new therapeutic methods that could significantly impact medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…